Gene Therapy & Gene Editing
Part of Healthcare - Genomics & Precision Medicine
 VRTX | Vertex Pharmaceuticals Inc | $119.5b | $545.52 | -1.0% | 556.1K |
 REGN | Regeneron Pharmaceuticals Inc | $78.2b | $812.58 | -2.2% | 291.5K |
 INSM | Insmed, Inc. | $21.4b | $125.08 | +0.4% | 1.1M |
 BMRN | BioMarin Pharmaceuticals Inc | $11.6b | $65.74 | -0.8% | 1.4M |
 KRYS | Krystal Biotech, Inc. Common Stock | $10.1b | $358.50 | +1.1% | 246.3K |
 CRSP | CRISPR Therapeutics AG | $4.7b | $59.41 | -2.7% | 837.6K |
 FOLD | Amicus Therapeutics, Inc | $4.5b | $14.49 | +0.0% | 3.5M |
 QURE | uniQure N.V. | $3.1b | $50.46 | -0.2% | 823.2K |
 BEAM | Beam Therapeutics Inc. Common Stock | $2.6b | $30.41 | -2.6% | 1.0M |
 VCEL | Vericel Corporation | $2.4b | $42.44 | -1.9% | 248.7K |
 PGEN | Precigen, Inc. Common Stock | $2.4b | $7.59 | +1.6% | 6.8M |
 SRPT | Sarepta Therapeutics,, Inc. Common Stock | $1.7b | $19.36 | +2.9% | 2.1M |
 TSHA | Taysha Gene Therapies, Inc. Common Stock | $1.7b | $6.12 | -3.1% | 1.1M |
 BLFS | BioLife Solutions Inc. | $1.5b | $37.12 | -0.6% | 787.1K |
 NTLA | Intellia Therapeutics, Inc | $1.5b | $13.40 | -2.4% | 2.4M |
 MGTX | MeiraGTx Holdings plc Ordinary Shares | $1.1b | $14.55 | -2.4% | 535.7K |
 PCRX | Pacira BioSciences, Inc. Common Stock | $1.1b | $25.91 | +1.6% | 432.4K |
 SANA | Sana Biotechnology, Inc. Common Stock | $0.9b | $4.17 | +1.5% | 2.1M |
 SLDB | Solid Biosciences Inc. Common Stock | $0.8b | $9.73 | -1.5% | 497.7K |
 DSGN | Design Therapeutics, Inc. Common Stock | $0.8b | $15.58 | -0.7% | 670.2K |
 CYRX | CryoPort, Inc. Common Stock | $0.8b | $16.57 | -0.9% | 220.6K |
 NGNE | Neurogene, Inc. Common Stock | $0.7b | $38.34 | -4.9% | 158.3K |
 ALLO | Allogene Therapeutics, Inc. Common Stock | $0.6b | $2.04 | -6.5% | 4.7M |
 RGNX | REGENXBIO Inc. | $0.6b | $9.24 | +5.4% | 963.4K |
 FDMT | 4D Molecular Therapeutics, Inc. Common Stock | $0.5b | $15.74 | -1.1% | 620.8K |
 PRME | Prime Medicine, Inc. Common Stock | $0.5b | $3.45 | -3.5% | 1.7M |
 KYTX | Kyverna Therapeutics, Inc. Common Stock | $443.8m | $8.61 | -2.4% | 380.6K |
 CABA | Cabaletta Bio, Inc. Common Stock | $437.0m | $3.21 | +1.2% | 2.2M |
 OCGN | Ocugen, Inc. Common Stock | $423.9m | $1.41 | +1.4% | 1.7M |
 BNTC | Benitec Biopharma Inc. Common Stock | $402.3m | $12.87 | -0.9% | 50.9K |
 EDIT | Editas Medicine, Inc. Common Stock | $395.9m | $3.21 | -3.4% | 2.7M |
 RCKT | Rocket Pharmaceuticals, Inc. Common Stock | $372.4m | $3.73 | -2.9% | 1.1M |
 ABEO | Abeona Therapeutics Inc. Common Stock | $365.9m | $6.09 | -3.2% | 1.1M |
 LXEO | Lexeo Therapeutics, Inc. Common Stock | $324.3m | $5.00 | -2.4% | 584.4K |
 IRD | Opus Genetics, Inc. Common Stock | $306.3m | $3.79 | -7.8% | 837.5K |
 TRDA | Entrada Therapeutics, Inc. Common Stock | $281.8m | $7.13 | -7.6% | 198.7K |
 VYGR | Voyager Therapeutics, Inc. Common Stock | $181.3m | $3.44 | -0.7% | 246.9K |
 DTIL | Precision BioSciences, Inc. Common Stock | $180.4m | $8.68 | -0.8% | 240.2K |
 TNYA | Tenaya Therapeutics, Inc. Common Stock | $158.2m | $0.70 | -0.2% | 903.2K |
 KRRO | Korro Bio, Inc. Common Stock | $149.6m | $13.66 | +0.9% | 34.5K |
 CBUS | Cibus, Inc. Class A Common Stock | $147.3m | $1.69 | -0.6% | 85.8K |
 CRBU | Caribou Biosciences, Inc. Common Stock | $144.8m | $1.66 | -6.5% | 788.6K |
 GNLX | Genelux Corporation Common Stock | $131.8m | $2.74 | +0.4% | 263.8K |
 ENGN | enGene Therapeutics Inc. Common Stock | $119.9m | $1.90 | +4.3% | 1.8M |
 MXCT | MaxCyte, Inc. Common Stock | $114.6m | $1.33 | -3.0% | 281.7K |
 SGMO | Sangamo Therapeutics, Inc. Common Stock | $83.3m | $0.18 | -17.5% | 6.9M |
 INO | Inovio Pharmaceuticals, Inc. | $55.7m | $1.28 | +1.2% | 3.7M |
 TIL | Instil Bio, Inc. Common Stock | $49.0m | $7.82 | 0.0% | 10.5K |
 TCRX | TScan Therapeutics, Inc. Common Stock | $47.3m | $0.78 | -2.1% | 66.1K |
 MGX | Metagenomi Therapeutics, Inc. Common Stock | $45.6m | $1.22 | +0.8% | 58.9K |